Stocks › I › IGXT

IntelGenx Technologies Corp. (IGXT) — Earnings Call X-Ray

Our AI read all 28 of IGXT's earnings calls (2016–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q4 2023 · sign up to see
Previous Call Grade
D
Q3 2023
Expected Move
🔒
next 45 days · members
Calls Analyzed
28
2016–2024
Avg Candor
6.1/9
evasion 4.5/9
High CandorCritic AmmunitionDeferred Revenue GrowingVolume Step-UpUnderused Fixed CostsDemand AcceleratingBacklog GrowingCapex Increasing

Call-by-call analysis

🔒 Q4 2023 earnings call 2024-03-21 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor ■/9
Specificity ■/9
Evasion ■/9
Stress ■/9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q4 2023 call grade is ready
The full 37-point AI read of IGXT's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

D Q3 2023 earnings call 2023-11-09

Management gave no formal guidance against accelerating demand. The delivery was unusually candid, rich in specifics.

Demand: acceleratingBacklog: growingPricing: stableCapex: increasing 5 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Prepayments growing✓ Volume step-up aheadDirection beats results
Candor 7/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q2 2023 earnings call 2023-08-14

Management gave no formal guidance against contracting margins. The delivery was frequently evasive, visibly under pressure.

Margins: contractingCapex: flat 9 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up aheadDirection beats results
Candor 5/9
Specificity 5/9
Evasion 7/9
Confidence 5/9
Uncertainty 6/9
Promotion 4/9
Stress 7/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q1 2023 earnings call 2023-05-11

Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid.

Demand: mixedMargins: contracting 8 analysts · 33 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 7/9
Specificity 6/9
Evasion 5/9
Confidence 6/9
Uncertainty 5/9
Promotion 6/9
Stress 5/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
YES Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q4 2022 earnings call 2023-03-29

Management gave no formal guidance against contracting margins. The delivery was rich in specifics.

Margins: contractingHeadcount: flat 6 analysts · 26 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 6/9
Specificity 7/9
Evasion 5/9
Confidence 5/9
Uncertainty 7/9
Promotion 4/9
Stress 4/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q3 2022 earnings call 2022-11-17

Management gave no formal guidance against slowing demand and contracting margins.

Demand: slowingMargins: contracting
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
Candor 5/9
Specificity 6/9
Evasion 3/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q2 2022 earnings call 2022-08-11

Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was rich in specifics.

Demand: mixedMargins: contractingPricing: stable 10 analysts · 29 questions
⚑ Critic ammunition⚑ Question left hangingFounder-ledDirection beats results
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q1 2022 earnings call 2022-05-12

Management gave no formal guidance against steady demand and contracting margins.

Demand: stableMargins: contracting 6 analysts · 16 questions
⚑ Critic ammunition⚑ Question left hangingFounder-ledDirection beats results
Candor 5/9
Specificity 5/9
Evasion 4/9
Confidence 6/9
Uncertainty 4/9
Promotion 3/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2021 2022-03-24 F noneunclearcontracting 6/9 5/9
Q3 2021 2021-11-11 D noneunclearcontracting 6/9 5/9
Q2 2021 2021-08-04 F noneunclearcontracting 4/9 5/9
Q1 2021 2021-05-13 D nonemixedunclear 7/9 4/9
Q4 2020 2021-03-25 D nonestableexpanding 6/9 3/9
Q3 2020 2020-11-12 F noneacceleratingexpanding 6/9 3/9
Q2 2020 2020-08-13 F noneslowingunclear 6/9 5/9
Q1 2020 2020-05-14 F noneunclearcontracting 7/9 4/9
Q3 2019 2019-11-10 F noneunclearcontracting 6/9 5/9
Q2 2019 2019-08-08 F noneunclearcontracting 6/9 4/9
Q4 2018 2019-03-25 F noneunclearcontracting 6/9 5/9
Q3 2018 2018-11-11 F noneunclearcontracting 5/9 7/9
Q2 2018 2018-08-10 F maintainedunclearcontracting 7/9 5/9
Q2 2017 2017-08-10 D nonestableexpanding 6/9 5/9
Q1 2017 2017-05-11 C noneacceleratingunclear 7/9 3/9
Q4 2016 2017-03-28 D nonestablecontracting 6/9 4/9
Q3 2016 2016-11-10 D nonestableunclear 6/9 4/9
Q2 2016 2016-08-11 C nonestablecontracting 7/9 4/9
Q1 2016 2016-05-12 F nonestablecontracting 6/9 5/9
Q4 2015 2016-03-23 D noneacceleratingexpanding 6/9 5/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAC · AAC Holdings'AACAY · AAC Technologies HoldingAACG · ATA Creativity GlobalAADI · Aadi Bioscience, Inc.AALBF · Aalberts N.V.AAOI · Applied Optoelectronics,

← IGT   All “I” companies    IH →

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.